Back
Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison
Sell
33
ALPMY
Astellas Pharma
Last Price:
11.15
Seasonality Move:
1.26%
Sell
43
SOLTF
Nxera Pharma
Last Price:
7.75
Seasonality Move:
4.96%
Sell
33
Astellas Pharma (ALPMY)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMY] share price is $11.40. The Score for ALPMY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ALPMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $7.75. The Score for SOLTF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALPMY Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $11.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing selling pressure, which indicates risk of future bearish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $7.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
ALPMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 44.53 | Sell |
| Chaikin Money Flow: | -54450 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.42 - 11.82) | Sell |
| Bollinger Bands (100): | (10.39 - 12.21) | Buy |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 43.95 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.26 - 8.94) | Sell |
| Bollinger Bands (100): | (8.27 - 10.23) | Sell |
ALPMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.63 | Sell |
| 20-day SMA: | 11.63 | Sell |
| 50-day SMA: | 11.92 | Sell |
| 200-day SMA: | 10.87 | Buy |
| 8-day EMA: | 11.62 | Sell |
| 20-day EMA: | 11.66 | Sell |
| 50-day EMA: | 11.66 | Sell |
| 200-day EMA: | 11.47 | Sell |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.38 | Buy |
| 20-day SMA: | 7.87 | Sell |
| 50-day SMA: | 8.55 | Sell |
| 200-day SMA: | 9.53 | Sell |
| 8-day EMA: | 7.52 | Buy |
| 20-day EMA: | 7.81 | Sell |
| 50-day EMA: | 8.43 | Sell |
| 200-day EMA: | 9.57 | Sell |
Astellas Pharma Earnings Growth & ALPMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||